Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,202 | 34 | 62.9% |
| Food and Beverage | $8,689 | 355 | 18.1% |
| Travel and Lodging | $4,337 | 30 | 9.0% |
| Consulting Fee | $4,120 | 3 | 8.6% |
| Education | $640.40 | 10 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $18,015 | 60 | $0 (2024) |
| GENZYME CORPORATION | $11,788 | 55 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $11,400 | 83 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,127 | 21 | $0 (2024) |
| LEO Pharma Inc. | $1,090 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $839.52 | 32 | $0 (2024) |
| ABBVIE INC. | $721.00 | 41 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $420.71 | 16 | $0 (2024) |
| PFIZER INC. | $386.66 | 18 | $0 (2024) |
| Incyte Corporation | $356.23 | 14 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,323 | 131 | GENZYME CORPORATION ($3,484) |
| 2023 | $13,936 | 108 | GENZYME CORPORATION ($8,058) |
| 2022 | $13,473 | 115 | Amgen Inc. ($6,594) |
| 2021 | $9,256 | 78 | Amgen Inc. ($7,976) |
All Payment Transactions
432 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $9.91 | General |
| Category: Inflammation & Immunology | ||||||
| 12/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $2.39 | General |
| Category: DERMATOLOGY | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: DERMATOLOGY | ||||||
| 11/27/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: DERMATOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.73 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.45 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Podiatry | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.71 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: DERMATOLOGY | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.84 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $27.11 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,090 | 1,955 | $237,690 | $48,467 |
| 2022 | 14 | 1,018 | 2,215 | $223,529 | $52,484 |
| 2021 | 13 | 1,065 | 2,099 | $175,592 | $55,683 |
| 2020 | 12 | 958 | 1,867 | $153,806 | $41,660 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 231 | 260 | $58,168 | $11,151 | 19.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 105 | 119 | $31,670 | $7,181 | 22.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 116 | 127 | $31,292 | $6,354 | 20.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 211 | 235 | $37,786 | $6,306 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 63 | $18,267 | $4,407 | 24.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 163 | 850 | $12,904 | $3,122 | 24.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 29 | 32 | $12,792 | $2,682 | 21.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $11,229 | $2,227 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,789 | $1,556 | 22.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 47 | $6,331 | $1,438 | 22.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 33 | 50 | $5,895 | $1,384 | 23.5% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 16 | 29 | $4,326 | $611.33 | 14.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 26 | 81 | $240.48 | $48.72 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 254 | 336 | $59,558 | $14,565 | 24.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 186 | 256 | $36,436 | $6,988 | 19.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 116 | 137 | $32,509 | $6,687 | 20.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 93 | 120 | $25,790 | $6,633 | 25.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 147 | 1,039 | $15,453 | $3,990 | 25.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 32 | 43 | $15,553 | $3,988 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 37 | $9,087 | $2,256 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 45 | $5,693 | $1,519 | 26.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 38 | 54 | $6,546 | $1,508 | 23.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $4,966 | $1,339 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $3,811 | $1,141 | 29.9% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 13 | 35 | $4,313 | $951.14 | 22.1% |
About Abigail James, NURSE PRACTITIONER
Abigail James, NURSE PRACTITIONER is a Nurse Practitioner healthcare provider based in Brentwood, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1285755538.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Abigail James, NURSE PRACTITIONER has received a total of $47,988 in payments from pharmaceutical and medical device companies, with $11,323 received in 2024. These payments were reported across 432 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,202).
As a Medicare-enrolled provider, James has provided services to 4,131 Medicare beneficiaries, totaling 8,136 services with total Medicare billing of $198,294. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Brentwood, TN
- Active Since 04/03/2007
- Last Updated 12/29/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1285755538
Products in Payments
- DUPIXENT (Biological) $19,753
- Otezla (Drug) $17,897
- COSENTYX (Biological) $839.30
- TREMFYA (Drug) $797.14
- OPZELURA (Drug) $356.23
- SKYRIZI (Biological) $304.21
- Puraply (Medical Supply) $297.68
- RINVOQ (Biological) $277.89
- EUCRISA (Drug) $275.49
- COSENTYX (Drug) $262.19
- Sotyktu (Drug) $241.21
- Seysara (Drug) $170.55
- TALTZ (Drug) $159.57
- Bimzelx (Biological) $158.52
- VTAMA (Drug) $148.86
- ILUMYA (Biological) $140.48
- HUMIRA (Biological) $122.02
- Enbrel (Biological) $117.28
- LITFULO (Drug) $101.26
- Winlevi (Drug) $86.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Brentwood
Angela Morehead, Fnp, FNP
Nurse Practitioner — Payments: $58,947
Amy Hendon, Np, NP
Nurse Practitioner — Payments: $2,092
Abigail Davis, Aprn, APRN
Nurse Practitioner — Payments: $1,932
Stefanie Morris, Fnp, FNP
Nurse Practitioner — Payments: $799.37
Mrs. Adeline Rouser, Np, NP
Nurse Practitioner — Payments: $696.53
Amanda Kralick, Np, NP
Nurse Practitioner — Payments: $371.70